Current trend of pneumococcal serotypes distribution and antibiotic susceptibility pattern in Malaysian hospitals

Vaccine. 2011 Aug 5;29(34):5688-93. doi: 10.1016/j.vaccine.2011.06.004. Epub 2011 Jun 30.

Abstract

From January 2008 to December 2009, 433 Streptococcus pneumoniae strains were examined to determine the serotype distribution and susceptibility to selected antibiotics. About 50% of them were invasive isolates. The strains were isolated from patients of all age groups and 33.55% were isolated from children below 5 years. The majority was isolated from blood (48.53%) and other sterile specimens (6.30%). Community acquired pneumonia (41.70%) is the most common diagnosis followed by sepsis (9.54%). Serotyping was done using Pneumotest Plus-Kit and antibiotic susceptibility pattern was determined by modified Kirby-Bauer disk diffusion method and measurement of minimum inhibitory concentration (MIC) using E-test strip. Ten most common serotypes were 19F (15.02%), 6B (10.62%), 19A (6.93%), 14 (6.70%), 1 (5.08%), 6A (5.08%), 23F (4.85%), 18C (3.93%), 3 (2.08%) and 5 (1.85%). Penicillin MIC ranged between ≤ 0.012-4 μg/ml with MIC₉₀ of 1 μg/ml. Penicillin resistant rate is 31.78%. The majority of penicillin less-susceptible strains belonged to serotype 19F followed by 19A and 6B. Based on the serotypes distribution 22 (44.00%), 28 (56.00%) and 39 (78.00%) of the invasive isolates from children ≤ 2 years were belonged to serotypes included in the PCV7, PCV10 and PCV13, respectively.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Bacterial Agents / pharmacology
  • Child
  • Child, Preschool
  • Community-Acquired Infections / microbiology
  • Disk Diffusion Antimicrobial Tests
  • Drug Resistance, Bacterial*
  • Female
  • Humans
  • Infant
  • Malaysia
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Pneumococcal Infections
  • Pneumonia / microbiology
  • Serotyping*
  • Streptococcus pneumoniae* / classification
  • Streptococcus pneumoniae* / drug effects
  • Streptococcus pneumoniae* / immunology
  • Streptococcus pneumoniae* / isolation & purification

Substances

  • Anti-Bacterial Agents